Anti-ADAM28 antibody for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9845364
SERIAL NO

14440391

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KEIO UNIVERSITYTOKYO 108-8345
GENEFRONTIER CORPORATIONCHIBA 277-0005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hayami, Yuki Kashiwa, JP 7 11
Katoh, Shizue Kashiwa, JP 10 16
Matsumoto, Rena Kashiwa, JP 2 2
Miyakoshi, Akira Kashiwa, JP 13 21
Mochizuki, Satsuki Tokyo, JP 5 3
Okada, Yasunori Tokyo, JP 28 250
Shimoda, Masayuki Tokyo, JP 31 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00